Dhaka has emerged as the top region for antibiotic use in Bangladesh, accounting for 57% of the country’s total consumption, according to the latest National Antimicrobial Resistance (AMR) Surveillance report. The study, presented by IEDCR’s chief scientific officer Dr. Zakir Hossain Habib, revealed alarming levels of drug-resistant bacteria in hospitals, particularly in intensive care units (ICUs). About 41% of ICU samples were found to be pan-drug resistant, meaning no tested antibiotics were effective. Overall, 46% of hospital samples showed multidrug resistance, rising to 89% in ICUs. Experts cautioned that Bangladesh is approaching a dangerous “post-antibiotic era” where common infections could become life-threatening. The surveillance, conducted under WHO’s Global Action Plan, analyzed over 96,000 clinical samples from 2016 to 2024. The most prevalent bacteria identified were E. coli (35%) and Klebsiella pneumoniae (19.2%), with young adults aged 21–30 being the highest antibiotic users.